3 Dividend Stocks to Buy and Hold for the Next Decade [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Three Motley Fool contributors think they've found great dividend stocks to own for the long term that pay you to wait for better days. Here's why they picked AbbVie (NYSE: ABBV) Amgen (NASDAQ: AMGN) , and Eli Lilly (NYSE: LLY) Keith Speights (AbbVie): Unlike most stocks, AbbVie's share price is up by a double-digit percentage so far in 2025. Investors know that the big pharmaceutical company's products will be in demand, regardless of what happens with the economy or the stock market. I like AbbVie's resilience. The company is coming off the patent expiration for its longtime top-selling drug, Humira. But AbbVie planned exceptionally well for this loss of exclusivity. Its two successors to Humira (Rinvoq and Skyrizi) are on track to generate more sales combined than Humira did at its peak. AbbVie has also completed several important acquisitions in recent years. These deals added major growth drivers to the company's lineup, including cancer drug Elahere, cosmetic therapy Boto
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly and Company (NYSE:LLY) was given a new $1,230.00 price target on by analysts at Daiwa Capital Markets. They now have a "buy" rating on the stock.MarketBeat
- Where Will Eli Lilly Be in 10 Years? [Yahoo! Finance]Yahoo! Finance
- 2 Predictions for Eli Lilly in 2026 [Yahoo! Finance]Yahoo! Finance
- Why Eli Lilly (LLY) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/8/25 - Form 3
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- LLY's page on the SEC website